Jeffrey Parvin

Title: The Innovations of Jeffrey Parvin

Introduction

Jeffrey Parvin is a notable inventor based in Lincoln, MA (US). He has made significant contributions to the field of virology, particularly in the development of recombinant negative strand RNA virus expression systems and vaccines. His work has implications for the creation of effective vaccines and therapeutic strategies.

Latest Patents

Parvin holds a patent for "Recombinant negative strand RNA virus expression systems and vaccines." This patent describes recombinant negative-strand viral RNA templates that can be utilized with purified RNA-directed RNA polymerase complex to express heterologous gene products in suitable host cells. The RNA templates are prepared through the transcription of specific DNA sequences using a DNA-directed RNA polymerase. The resulting RNA templates possess negative polarity and include terminal sequences that enable the viral RNA-synthesizing apparatus to recognize the template. Additionally, bicistronic mRNAs can be constructed to facilitate internal initiation of translation of viral sequences, allowing for the expression of foreign protein coding sequences.

Career Highlights

Jeffrey Parvin is associated with Medimmune Vaccines, Inc., where he continues to advance his research in vaccine development. His innovative approaches have positioned him as a key figure in the field of virology.

Collaborations

Throughout his career, Parvin has collaborated with esteemed colleagues such as Mark R. Krystal and Peter M. Palese. These collaborations have further enriched his research and contributed to advancements in vaccine technology.

Conclusion

Jeffrey Parvin's work in recombinant negative strand RNA virus expression systems exemplifies the innovative spirit of modern science. His contributions are paving the way for future advancements in vaccine development and therapeutic interventions.